KEYWORDS
Access, Representation, Population Health, Technology and Procedures, Assays, Imaging, Treatment Considerations, Combination Therapy, Drug Development, Supportive Care, Therapy Sequence, Biological Therapies, Antibody Therapy, Transfusion, Non-Biological Therapies, Pharmacology, Women’s Health, Adverse Events, Biological Processes, Pathogenesis, Hematopoiesis, Immune Mechanism, Metabolism, Clinical Practice (Health Services and Quality), Patient Safety, Quality Improvement, Value, Diseases, Bleeding and Clotting, Bleeding Disorders, Bone Marrow Failure Syndromes, Acquired Marrow Failure Syndromes , Hemoglobinopathies, Sickle Cell Disease, Sickle Cell Trait, Thalassemia, Infectious Diseases, Myeloid Malignancies, Metabolic Disorders, Iron Deficiency, Iron Overload, Research, Fundamental Science, Translational Research, Clinical Research, Clinical Trials, Patient-Reported Outcomes, Real-World Evidence, Study Population, Human, Adult, Young Adult, Animal Model